From: The clinical relevance of autoantibodies in scleroderma
SSc versus: | Assay used | Sensitivity (%) | Specificity (%) |
---|---|---|---|
Normal controls | ID | 20* | 100* |
 | IB | 41* | 99.4* |
 | ELISA | 43* | 100* |
 | Overall | 34†| 99.6†|
Other connective tissue diseases | ID | 26* | 99.5* |
 | IB | 40* | 99* |
 | ELISA | 43* | 90* |
 | Overall |  | 97.9†|
Primary Raynaud's phenomenon | ID | 28* | 98* |
Non-SSc relatives | ID | 25.5* | 100* †|